Foxp3
CONICET specialists successfully halt a type of brain cancer in preclinical studies with a novel therapeutic strategy
·6 mins
Notaspampeanas
CONICET
Glioblastoma
Cancer
Foxp3
INBIOMED
P60
Brain Cancer
Therapeutic Strategy